129 related articles for article (PubMed ID: 32678293)
1. Combination of apolipoprotein-A-I/apolipoprotein-A-I binding protein and anti-VEGF treatment overcomes anti-VEGF resistance in choroidal neovascularization in mice.
Zhu L; Parker M; Enemchukwu N; Shen M; Zhang G; Yan Q; Handa JT; Fang L; Fu Y
Commun Biol; 2020 Jul; 3(1):386. PubMed ID: 32678293
[TBL] [Abstract][Full Text] [Related]
2. Combination of AIBP, apoA-I, and Aflibercept Overcomes Anti-VEGF Resistance in Neovascular AMD by Inhibiting Arteriolar Choroidal Neovascularization.
Zhang Z; Shen MM; Fu Y
Invest Ophthalmol Vis Sci; 2022 Nov; 63(12):2. PubMed ID: 36318195
[TBL] [Abstract][Full Text] [Related]
3. Treatment Strategies for Anti-VEGF Resistance in Neovascular Age-Related Macular Degeneration by Targeting Arteriolar Choroidal Neovascularization.
Fu Y; Zhang Z; Webster KA; Paulus YM
Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540673
[TBL] [Abstract][Full Text] [Related]
4. Serine racemase deficiency attenuates choroidal neovascularization and reduces nitric oxide and VEGF levels by retinal pigment epithelial cells.
Jiang H; Wu M; Liu Y; Song L; Li S; Wang X; Zhang YF; Fang J; Wu S
J Neurochem; 2017 Nov; 143(3):375-388. PubMed ID: 28892569
[TBL] [Abstract][Full Text] [Related]
5. Lactic Acid Upregulates VEGF Expression in Macrophages and Facilitates Choroidal Neovascularization.
Song J; Lee K; Park SW; Chung H; Jung D; Na YR; Quan H; Cho CS; Che JH; Kim JH; Park JH; Seok SH
Invest Ophthalmol Vis Sci; 2018 Jul; 59(8):3747-3754. PubMed ID: 30046816
[TBL] [Abstract][Full Text] [Related]
6. AIBP and APOA-I synergistically inhibit intestinal tumor growth and metastasis by promoting cholesterol efflux.
Zhang T; Wang Q; Wang Y; Wang J; Su Y; Wang F; Wang G
J Transl Med; 2019 May; 17(1):161. PubMed ID: 31101050
[TBL] [Abstract][Full Text] [Related]
7. Co-inhibition of PGF and VEGF blocks their expression in mononuclear phagocytes and limits neovascularization and leakage in the murine retina.
Balser C; Wolf A; Herb M; Langmann T
J Neuroinflammation; 2019 Feb; 16(1):26. PubMed ID: 30732627
[TBL] [Abstract][Full Text] [Related]
8. Retinal Inhibition of CCR3 Induces Retinal Cell Death in a Murine Model of Choroidal Neovascularization.
Wang H; Han X; Gambhir D; Becker S; Kunz E; Liu AJ; Hartnett ME
PLoS One; 2016; 11(6):e0157748. PubMed ID: 27309355
[TBL] [Abstract][Full Text] [Related]
9. Effects of an anti-VEGF-A monoclonal antibody on laser-induced choroidal neovascularization in mice: optimizing methods to quantify vascular changes.
Campa C; Kasman I; Ye W; Lee WP; Fuh G; Ferrara N
Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1178-83. PubMed ID: 18326747
[TBL] [Abstract][Full Text] [Related]
10. [Expression of vascular endothelial growth factor and its receptor in experimental choroidal neovascularization in rat].
Zhao SH; He SZ; Shi XH
Zhonghua Yan Ke Za Zhi; 2004 Aug; 40(8):522-7. PubMed ID: 15454039
[TBL] [Abstract][Full Text] [Related]
11. Technetium-99 conjugated with methylene diphosphonate (99Tc-MDP) inhibits experimental choroidal neovascularization in vivo and VEGF-induced cell migration and tube formation in vitro.
Lai K; Xu L; Jin C; Wu K; Tian Z; Huang C; Zhong X; Ye H
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5702-12. PubMed ID: 21666238
[TBL] [Abstract][Full Text] [Related]
12. Association between choroidal morphology and anti-vascular endothelial growth factor treatment outcome in myopic choroidal neovascularization.
Ahn SJ; Woo SJ; Kim KE; Park KH
Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):2115-22. PubMed ID: 23462751
[TBL] [Abstract][Full Text] [Related]
13. Predictors of treatment response to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy for choroidal neovascularisation secondary to chronic central serous chorioretinopathy.
Romdhane K; Zola M; Matet A; Daruich A; Elalouf M; Behar-Cohen F; Mantel I
Br J Ophthalmol; 2020 Jul; 104(7):910-916. PubMed ID: 31615761
[TBL] [Abstract][Full Text] [Related]
14. Correlation of CD105 and vascular endothelial growth factor in laser-induced choroidal neovascularization in rats.
Xu J; Wang Y; Yang X; Zhang P; Chen L
Yan Ke Xue Bao; 2006 Sep; 22(3):166-74, 183. PubMed ID: 17162902
[TBL] [Abstract][Full Text] [Related]
15. β2-Adrenergic Receptor Antagonism Attenuates CNV Through Inhibition of VEGF and IL-6 Expression.
Lavine JA; Farnoodian M; Wang S; Darjatmoko SR; Wright LS; Gamm DM; Ip MS; Sorenson CM; Sheibani N
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):299-308. PubMed ID: 28114591
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of ocular neovascularization by co-inhibition of VEGF-A and PLGF.
Huo X; Li Y; Jiang Y; Sun X; Gu L; Guo W; Sun D
Cell Physiol Biochem; 2015; 35(5):1787-96. PubMed ID: 25832861
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Placenta Growth Factor Reduces Subretinal Mononuclear Phagocyte Accumulation in Choroidal Neovascularization.
Crespo-Garcia S; Corkhill C; Roubeix C; Davids AM; Kociok N; Strauss O; Joussen AM; Reichhart N
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):4997-5006. PubMed ID: 28979997
[TBL] [Abstract][Full Text] [Related]
18. Eicosapentaenoic acid is anti-inflammatory in preventing choroidal neovascularization in mice.
Koto T; Nagai N; Mochimaru H; Kurihara T; Izumi-Nagai K; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Oike Y; Ishida S
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4328-34. PubMed ID: 17724224
[TBL] [Abstract][Full Text] [Related]
19. Systemic rapamycin inhibits retinal and choroidal neovascularization in mice.
Dejneka NS; Kuroki AM; Fosnot J; Tang W; Tolentino MJ; Bennett J
Mol Vis; 2004 Dec; 10():964-72. PubMed ID: 15623986
[TBL] [Abstract][Full Text] [Related]
20. Early effects of intravitreal triamcinolone acetonide on inflammation and proliferation in human choroidal neovascularization.
Tatar O; Adam A; Shinoda K; Kaiserling E; Boeyden V; Claes C; Eckardt C; Eckert T; Pertile G; Scharioth GB; Yoeruek E; Szurman P; Bartz-Schmidt KU; Grisanti S
Arch Ophthalmol; 2009 Mar; 127(3):275-81. PubMed ID: 19273790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
